MASH
Strategies to Treat Liver Disease, From Traditional to Cutting-Edge
Lifestyle modifications and control of cardiometabolic risk factors are foundational to the management of all ...
AUGUST 26, 2025
Wegovy Approved to Treat MASH With Moderate to Advanced Fibrosis
The FDA has approved semaglutide in conjunction with diet and exercise for the treatment of MASH with moderate to ...
AUGUST 20, 2025
DDW 2025 Expert Picks, Part 1
In part 1 of the DDW Expert Picks column, we review top abstracts from the ASGE program ...
JULY 24, 2025
Expert Picks From The Liver Meeting 2024
In this second part of a two-part series, Ashwani Singal, MD, MS, discusses abstracts on treatment of severe ...
MAY 22, 2025
New Trials Suggest Promising Treatment Pipeline for MASH and MASLD
The results of several studies presented at The Liver Meeting 2024 suggest there is a robust treatment pipeline for ...
MAY 14, 2025
Nutritional Wellness to Prevent Worsening of Liver Disease
Matthew Kappus, MD, has a lofty goal: to elevate nutritional wellness in patients with liver disease and advanced ...
APRIL 4, 2025
Resmetirom With Weight Loss Improves MASH, Fibrosis
Patients with MASH fibrosis taking resmetirom who lost at least 5% of their body weight had a higher rate of ...
MARCH 7, 2025
Key Conference Highlights and Publications for APPs
From groundbreaking clinical trials to comprehensive educational opportunities at major conferences, APPs ...
FEBRUARY 20, 2025
Aerobic Exercise Can Resolve MASH, Even Without Weight Loss
Aerobic exercise training in patients with MASH resulted in increased likelihood of MASH resolution, even among ...
FEBRUARY 5, 2025
New Analyses Evaluate Resmetirom’s Effects on MASH and Fibrosis
Patients with MASH and F2 or F3 fibrosis treated with resmetirom had improvements in both fibrosis and MASH over 52 ...
JANUARY 13, 2025
Looking at Disease Course and Mortality in MASH Patients
A new study of patients with MASH shows a six-year mortality rate of 10% in patients with compensated cirrhosis.
JANUARY 9, 2025
Advanced Alcohol-Associated Liver Disease
Alcohol-associated liver disease is one of the most common liver diseases and its prevalence is increasing ...
NOVEMBER 11, 2024
